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Abstract 17 
 The analysis of time series data is common in nutrition and metabolism research for quantifying the 18 
physiological responses to various stimuli. The reduction of many data from a time series into a summary 19 
statistic(s) can help quantify and communicate the overall response in a more straightforward way and in 20 
line with a specific hypothesis. Nevertheless, many summary statistics have been selected by various 21 
researchers, and some approaches are still complex. The time-intensive nature of such calculations can be a 22 
burden for especially large datasets and may, therefore, introduce computational errors, which are difficult 23 
to recognize and correct. In this short commentary, we introduce a newly-developed tool that automates 24 
many of the processes commonly used by researchers for discrete-time series analysis, with particular 25 
emphasis on how the tool may be implemented within nutrition and exercise science research. 26 
Keywords 27 
Incremental area under the curve; time series data; temporal response; post-prandial. 28 
  29 
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Introduction 30 
It is common practice within the field of nutrition and metabolism research to analyses serial 31 
measurements made over time to determine the temporal pattern of a given response. Typical examples include 32 
metabolic control following nutritional challenges (i.e. oral glucose or fat tolerance tests; Berthiaume & Zinker, 33 
2002), monitoring of stable isotope enrichment in various body pools and associated substrate kinetics 34 
(Garlick et al., 1989), and markers of physiological response to exercise such as heart rate and oxygen 35 
consumption (Gore & Withers, 1990).  36 
 37 
Such analyses have become increasingly complex and necessary in recent years both due to technical 38 
advancements in measurement tools and due to our growing understanding of the interactions between various 39 
nutritional stimuli. Regarding the former, it is undoubtedly a mark of progress that modern technologies have 40 
enabled many measurements to be made with higher sampling frequency and thus with greater sensitivity to 41 
rapidly fluctuating responses over time. However, such high-resolution temporal data also bring certain 42 
analytical challenges (such as the control of type I and II error rates due to the number of multiple comparisons), 43 
which can complicate the elucidation and communication of clear conclusions.  44 
 45 
While early studies in many areas of nutrition science may have examined simple comparisons of 46 
treatments (e.g. 20 g carbohydrate versus water/placebo at a single time-point), the state of current 47 
understanding in many areas is now such that further progress requires more sophisticated factorial designs 48 
with multiple levels within each factor, to examine longer term effects and/or interactions between ingredients 49 
that work in concert (e.g. pre-post response to carbohydrate versus carbohydrate-protein versus water/placebo, 50 
etc.). This further evolution is necessary to detect more subtle and/or context specific effects but, again, 51 
introduces additional complicating factors, such as the reduced statistical power associated with quantifying 52 
interactive effects between all the additional independent variables (e.g. a 3-way ANOVA: 3 conditions*pre-53 
post*multiple time-points), along with the complications arising when the data violate the assumption of 54 
sphericity (Huck & Cormier, 1995).  55 
 56 
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In all the above cases, condensing the time series data down to a summary statistic can simplify the 57 
analysis by removing the temporal element. In the above example, the 3-way ANOVA with multiple 58 
comparisons at many time-points becomes a 2-way condition*time (pre, post) analysis. Beyond these 59 
advantages in relation to statistical analyses, this approach of using summary statistics facilitates the clear 60 
communication of the main findings both in simple terms for the general public and with complete reporting 61 
of individual responses for the scientific community. For example, graphical presentation of time series data 62 
on a line graph does not readily allow for individual or paired responses to be plotted, whereas this consistency 63 
of observed responses is easily presented as a histogram showing individual summary statistics (Figure 1). 64 
Measures of central tendency certainly have a place to illustrate group effects on graphs and figures but 65 
individual responses to each experimental condition should still be presented, particularly when sample sizes 66 
are relatively small, to facilitate critical evaluation of data (Weissgerber et al., 2015). 67 
 68 
Despite the above benefits of summary statistics and the common use of time series experimental 69 
designs within the scientific literature, the general approaches and precise methods of analysis vary 70 
considerably between laboratories and experiments (Wolever, 2004; Matthan et al., 2016). In addition, 71 
calculations requiring multiple stages and various equations are time consuming and susceptible to human 72 
error. This short commentary introduces a downloadable spreadsheet, the Time Series Response Analyser 73 
(TSRA), designed specifically to automate and standardize many common processes, thus minimizing both 74 
the time spent analyzing data and the probability of computational errors. The TSRA is freely available under 75 
the ‘Author Guidelines’ section of the IJSNEM website 76 
(https://journals.humankinetics.com/view/journals/ijsnem/ijsnem-overview.xml/). This commentary will 77 
highlight a range of time series analysis procedures that can be computed with the tool, and briefly discuss 78 
their utility in the context of exercise and nutrition research. 79 
 80 
Area under the curve (AUC) 81 
The methodological approach to an AUC calculation is particularly variable (Wolever, 2004) and 82 
manual calculation is highly susceptible to human error. The AUC can be calculated using denominations of 83 
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the trapezoidal rule, where time series data are integrated to form a single value characterizing the overall 84 
response, representative of an area (e.g. blood glucose concentrations measured in mmol·l-1 at serial time-85 
points over a standard oral glucose tolerance test are expressed as the product of concentration and time; 86 
mmol·l-1·120 min). Figure 2 illustrates a range of AUC options, each of which is described in this section. 87 
 88 
Total AUC is the most straightforward approach, in which an area is calculated relative to the line 89 
representing an ordinate of zero (Matthews et al., 1990). This practice can provide a valid estimate of the 90 
overall exposure to the parameter of interest (i.e. including the value measured at baseline – e.g. if contrasting 91 
24 h plasma testosterone concentrations between males and females). However, by the same reasoning, total 92 
AUC can be limited by the variation commonly observed at baseline, despite the best efforts of researchers 93 
and participants to replicate experimental conditions (Altman, 1985). In cases where baseline differences are 94 
apparent and/or it is the response to a stimulus that is of primary interest, the incremental AUC relative to 95 
another nominal value (generally baseline) may be a more appropriate alternative (Wolever & Jenkins, 1986). 96 
 97 
Naturally, certain exposures can cause the dependent variable to drop below the value to which 98 
incremental AUC is being calculated. For example, the postprandial response to a standard oral glucose 99 
tolerance test is typically measured across two hours, as the blood glucose concentrations of healthy 100 
participants tend to return to baseline within this time period (Babraj et al., 2009). Therefore, the blood glucose 101 
concentrations of highly insulin sensitive individuals could feasibly fall below the value measured at baseline, 102 
which for an incremental AUC calculation provides multiple options for analysis. In this instance some 103 
researchers may choose to terminate the calculation at the time-point at which the measured value falls below 104 
the incremental reference value (Ha et al., 1992), while others will include any subsequent positive segments 105 
if the value returns above baseline. Within this latter approach, researchers could consider negative areas to 106 
equal zero (Hofman et al., 2004), or subtract them from the calculation (Gannon et al., 1989). It should be 107 
noted that, while the subtraction of negative areas follows the principle of mathematical integration, this 108 
process is rarely justified but may occasionally be applied in error. In theory, unless this subtractive process 109 
is rationalized, values representing AUC should always be positive. Moreover, some of the incremental AUC 110 
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variations can be applied to the nadir rather than the baseline value (Vorster et al., 1990), which may be of 111 
interest when variables tend to decrease in response to a stimulus, such as postprandial concentrations of non-112 
esterified fatty acids (Bickerton et al., 2007), or the ‘hunger hormone’ ghrelin (le Roux et al., 2005). 113 
Alternatively, the AUC could be calculated relative to a pre-determined absolute value or clinical reference 114 
threshold that is indicative of a certain outcome (Monnier et al., 2003). It is beyond the scope of this 115 
commentary to discuss each of these methodologies in any greater detail as they ultimately depend on the 116 
context. Suffice to say, whilst some AUC calculations are relatively simple, others can become mathematically 117 
complex, particularly those that consider the intersection of certain thresholds. In these instances, the 118 
probability of conceptual and computational errors with manual calculations are increased, and the clarity with 119 
which the AUC values have been derived is reduced. 120 
The TSRA generates AUC results from raw data consistently and instantaneously with a minimal risk 121 
of human error. The tool computes AUC for all treatments simultaneously and handles each of the 122 
aforementioned methodologies under the input of the user. In addition, the spreadsheet provides transparency 123 
by explicitly quantifying the segmental areas that combine to produce the chosen AUC (which can be valuable 124 
information in itself to retain some reference to the shape of the response curve despite reducing the individual 125 
time points into areas). 126 
 127 
Alternative summary statistics in discrete-time series analysis 128 
 129 
In addition to the AUC calculations computed by the TSRA, the peak and time-to-peak values for each trial 130 
are also included in the output. Errors and inconsistencies in the identification of these summary statistics are 131 
considerably less likely to occur when compared to AUC, as their definitions are more precise and their 132 
calculations are more straightforward. They can however be particularly informative within certain contexts, 133 
and they are therefore briefly discussed in this section. Table 1 contains definitions, benefits, limitations and 134 
examples for each summary statistic included in the TSRA output. 135 
 136 
Peak 137 
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Of the various alternative summary values that can describe a time series response, the absolute peak 138 
is an easily identifiable, interpretable and physiologically meaningful statistic. It is simply the highest value 139 
attained in the dependent variable across the time window through which it was measured. Therefore, rather 140 
than representing the totality of a response, as is the case with AUC, this value indicates the maximum 141 
measured value of the relevant outcome. Critically, this statistic should be determined separately for every 142 
distinct trial and individual, accepting that the peak value may occur at different time-points for different 143 
response curves. Thus, the contrast of maximum measured values cannot be ascertained from visual inspection 144 
of the data when plotted as a time series (i.e. it is possible that no single participant’s maximum value occurred 145 
at the apex of the group mean line). The utility of a peak value during the response to a physiological challenge 146 
has been demonstrated in the diagnoses of various medical conditions such as growth hormone deficiency 147 
(Koppeschaar et al., 2004) and constitutional delay of puberty (Grinspon et al., 2010), and is practical in the 148 
application of diagnostic research due to the absence of any complex calculations. Despite the simplicity of 149 
this summary statistic representing a clear benefit of this approach, contextual limitations do exist. For 150 
example, measurement error is likely to be relatively high when a single data-point is used to summarize an 151 
overall response, and the accuracy is heavily influenced by the true location of a peak value relative to the 152 
frequency with which samples are collected (De Nicolao et al., 2000). The accuracy of this value may therefore 153 
be questioned when sampling frequency is insufficient and/or the random within-subjects variability or “noise” 154 
in the measurement of the dependent variable is high. 155 
 156 
Time-to-peak 157 
Alongside the reporting of the peak value, the time at which this peak occurs is typically reported and 158 
interpreted by authors. This “time-to-peak” summary statistic indicates the gradient of the response to the 159 
stimulus, demonstrating onset alongside magnitude. For example, both the AUC and peak values may be 160 
similar between treatments, yet the time-to-peak may still reveal important changes in the shape of the 161 
response curve (Figure 3). This may be useful when assessing the bioavailability of a nutrient or supplement, 162 
as it can indicate the net rate of appearance relative to an alternative condition (Matthews et al., 1990). For 163 
example, Vinson and Bose (1988) included a comparison of a time-to-peak summary statistic when 164 
8 
 
investigating ascorbic acid bioavailability, in response to the ingestion of equivalent doses of synthetic and 165 
naturally-occurring vitamin C. Importantly, unless a substance is not endogenously produced and maintains 166 
constant disappearance rates, or in the absence of isotopic tracer methodologies, this method provides fairly 167 
limited insight into substrate kinetics. However, the utility of the time-to-peak summary statistic as a 168 
diagnostic tool has been demonstrated in the context of insulin sensitivity. Specifically, risk-prediction models 169 
for prediabetes were shown to be reliably and independently enhanced by the addition of time-to-peak blood 170 
glucose concentration during an oral glucose tolerance test (Chung et al., 2017). Moreover, the use of this 171 
statistic in this context theoretically signified the early-phase insulin response, which may have provided 172 
additional mechanistic insight beyond alternative summary statistics (Cree-Green et al., 2018). 173 
 174 
A further application of time-to-peak has been to inform methodologies that seek to identify certain 175 
responses, such as the duration and sampling frequency of an oral fat tolerance test necessary to provide a 176 
holistic metabolic profile (Tentolouris et al., 2017). As with all considerations outlined in this paper, the 177 
precise calculations and reported outcomes should remain specific to the research question and will therefore 178 
depend heavily on the context in which time series data are being analyzed. Moreover, where the magnitude 179 
and/or timing of the peak is of interest, additional measurements should be taken throughout the time window 180 
within which it is expected to occur. 181 
 182 
Further considerations 183 
 184 
Variability statistics 185 
 Another avenue for investigation of time series data is variability. For example, measures of variability 186 
in the continuous monitoring of glucose concentrations can be a useful parameter to describe glycemic control 187 
(Wijsman et al., 2013). A greater variability in glucose concentration could indicate a reduced ability to 188 
appropriately respond to nutritional stimuli, reflecting impaired homeostatic regulation and in the context of 189 
glucose metabolism, an increased risk of type-2 diabetes (Ceriello et al., 2008). Within this example, a variety 190 
of methods are available to characterize glycemic variability including overall standard deviation, standard 191 
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deviation across fixed time windows (for variability changes across time), range, interquartile range, 192 
percentage coefficient of variation and time spent above/below certain thresholds (Akintola et al., 2015). 193 
Rodbard (2009) discussed these methods from a statistical standpoint and provided further context-specific 194 
options for alternative perspectives on time series data. Another context in which the variability in a measured 195 
marker is of interest within a certain time window is chronobiology. Whilst this is a particularly interesting 196 
avenue for time series data analysis in nutrition research, it is beyond the scope of the TSRA primarily because 197 
of the circular nature of chronobiological data measured over several biological rhythm periods. The 198 
intricacies of biological rhythm descriptions and summaries are discussed from a statistical perspective 199 
elsewhere (Landler, Ruxton & Malkemper, 2018). The appropriate application of variability statistics to time 200 
series data ultimately depends on the specific research question being addressed, and the information that each 201 
option can provide. Further key considerations may be the normality of data distribution, which can influence 202 
the appropriateness of certain measures of central tendency and variability, and the associated sensitivity of 203 
these approaches to more extreme values. The TSRA computes both the standard deviation and the coefficient 204 
of variation for each individual trial, and provides these simple variability statistics within the standard output. 205 
Alternative variability statistics are not calculated by the tool, as the provision of a finite number of complex 206 
options may influence the analytical approach taken by the user. 207 
 208 
Missing values 209 
Missing values may be the result of missed or inappropriately handled samples, errors in a 210 
measurement technique or mistakes during data entry. These can be particularly common in time series data, 211 
as the probability of an error is increased when a large number of samples are collected (especially where 212 
humans and/or technology are involved!). Missing data pose a problem for the analysis of time series data as 213 
the intended temporal resolution within a given trial is transiently reduced. Key considerations include the 214 
amount, the pattern and the cause of missing data, each of which may influence the methods by which they 215 
are resolved. Regarding the cause, data could be missing completely at random (MCAR), where missing values 216 
are unrelated to any observed values and are therefore a totally random subset of the data. Alternatively, if 217 
missing values are related to observed data, or dependent on the unobserved values themselves, they are 218 
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considered to be missing at random (MAR) or missing not at random (MNAR), respectively (Little & Rubin, 219 
1987). Where data are MCAR, techniques typically aim to preserve the observed underlying parameters of 220 
the variables for which data are imputed (e.g. means, variances, covariances etc.). However, the systematic 221 
nature of data MAR and MNAR suggest potential bias may have been introduced in these parameter estimates 222 
due to the existence of the missing values. For example, if the accuracy of a measurement technique utilized 223 
during time series data collection is confounded outside a certain range, especially high and/or low values are 224 
likely to be missing more frequently, eliciting an unrepresentatively skewed distribution (an example of 225 
MNAR). Indeed, Bell, King and Fairclough (2014) demonstrated a greater level of bias in time series summary 226 
measures with data MAR or MNAR, compared with MCAR, using a simulated randomized controlled trial. 227 
Researchers are therefore recommended to identify the cause of missing time series data and handle this issue 228 
accordingly. 229 
 230 
Individual time-points for continuous time series data are inherently not mutually exclusive, so it seems 231 
appropriate to estimate missing values using known data for a given trial. The precise method by which this 232 
process has been conducted may however be ambiguous. As AUC calculations follow the trapezoidal rule, 233 
this summary statistic would typically use simplistic linear interpolation to estimate missing values. Briefly, 234 
existing points either side of missing values are connected with a straight line, and these are imputed as a 235 
function of time using the resulting linear equation (Figure 4A). It should be noted that this approach has 236 
limitations, particularly if missing values occur where the true response is likely to have reached a peak, as a 237 
linear connection would undercut this value (Figure 4B). An alternative approach may be to fit a polynomial 238 
curve of appropriate order to the known data and impute missing values using the resulting polynomial 239 
equation. In the context of time series data, imputing missing values using alternative trials for the same 240 
treatment or the same individual are not recommended, as these approaches are likely confounded by inter-241 
individual variability and the effect of treatments, respectively. For a comprehensive review of missing value 242 
handling in the context of randomized controlled trials in nutrition, the reader is directed to Li and Stuart 243 
(2019). 244 
 245 
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Outliers 246 
 Another contentious topic in the initial screening of data is the identification and subsequent handling 247 
of outliers. Outlier identification typically uses statistical approaches, such as Tabachnick and Fidell (2007) 248 
defining values ≥ 3.29 standard deviations above or below the mean as outliers (the probability of obtaining a 249 
true sample this extreme is 0.1%). However, similar to missing values, continuous time series data are unique 250 
in that an outlier may be identifiable by its magnitude in relation to the rest of the response curve. This 251 
viewpoint may however lead to the exclusion of certain values simply because they don’t follow a relatively 252 
smooth pattern which, as measurement error is likely to exist in all samples, may be too subjective an approach. 253 
de Souza and colleagues (2015) advocate for data analyses to be conducted with and without suspected outliers, 254 
to assess whether the main analysis is robust to these extreme cases. Comprehensive reporting of this 255 
sensitivity analysis may then be the most transparent approach to the handling of outliers. 256 
 257 
Conclusion 258 
The TSRA has been specifically designed to speed up and standardize the calculation of summary 259 
statistics from time series data. Therefore, this tool can be used to validate calculations, and can then be cited 260 
in publications to provide transparency and to verify that the reported summary statistics are free from error. 261 
In turn, readers can have greater confidence in the reported conclusions. 262 
 263 
 264 
 265 
 266 
 267 
 268 
 269 
 270 
 271 
 272 
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Table 1. Summary of the various summary statistics available in the output of the TSRA. 
Summary 
Statistic 
Definition/Inference Advantages Limitations Examples in 
Nutrition and 
Exercise Science 
     
Area 
under the 
curve 
A value 
representative of the 
magnitude of the 
total response to a 
stimulus across a 
given time period, 
calculated using the 
trapezoidal rule. 
A single value that 
takes into account 
the two-
dimensionality of 
time-series data (e.g. 
both the magnitude 
and the duration of 
the response are 
accounted for) 
Inconsistent definitions 
throughout the literature 
Mathematical 
complexity increases 
probability of 
human/computational 
error 
Blood glucose and 
insulin 
concentration 
responses to an 
oral glucose 
tolerance test 
Appetite hormone 
responses to 
certain meals 
     
Peak The maximum 
measured value 
attained in response 
to the stimulus. 
Simple identification 
of the highest 
measured value 
Clearly indicative of 
the maximum 
instantaneous 
exposure to the 
stimulus 
Validity dependent on 
measurement frequency 
relative to true peak, 
and error associated 
with the measurement 
technique 
 
Diagnosis of 
diabetes during an 
oral glucose 
tolerance test 
Exogenous 
glucose oxidation 
rates during 
exercise, when 
comparing 
carbohydrate-
based sports 
drinks 
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Time to 
Peak 
The time taken to 
reach the maximum 
measured value. The 
onset of a given 
exposure. 
Simple identification 
of the time at which 
the highest measured 
value was sampled 
May provide insight 
into the early-phase 
response to a 
stimulus 
Validity dependent on 
measurement frequency 
relative to true peak, 
and error associated 
with the measurement 
technique 
Mechanistic inference 
may be confounded by 
contributing rates of 
appearance and 
disappearance 
Early-phase 
insulin response to 
an oral glucose 
tolerance test 
Oxygen uptake 
kinetics at the 
onset of steady-
state exercise 
Enhancing post-
exercise glycogen 
resynthesis rates 
     
Minimum The minimum value 
attained in response 
to a stimulus. 
Simple identification 
of the lowest 
measured value 
Validity dependent on 
measurement frequency 
relative to true nadir, 
and error associated 
with the measurement 
technique 
Analysis of 
variables that are 
known to decrease 
in response to a 
stimulus, such as 
plasma non-
esterified fatty 
acid or glucagon-
like peptide-1 
responses to 
carbohydrate 
ingestion 
     
Variability 
Statistics 
The degree to which 
a measured marker 
Calculations can be 
relatively 
straightforward (e.g. 
Wide range of 
variability statistics 
available 
Glycemic 
variability with 
continuous 
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varies throughout a 
given period of time. 
standard deviation, 
coefficient of 
variation etc.) 
Provides insight into 
holistic homeostatic 
control mechanisms 
Susceptible to 
confounding by the 
existence of outliers 
glucose 
monitoring data 
Exercise intensity 
variability during 
endurance events 
(e.g. heart rate or 
perceived exertion 
during a cycling 
road race) 
 379 
 380 
 381 
 382 
 383 
 384 
 385 
 386 
 387 
 388 
 389 
 390 
 391 
 392 
 393 
 394 
 395 
 396 
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Figure Legends 397 
 398 
Figure 1. 90-minute blood glucose concentration response to milkshake ingestion under two conditions 399 
(breakfast-rest vs. breakfast-exercise). Data are presented as individual measured responses across time (A), 400 
and using the incremental area under the curve (AUC) summary statistic displayed as mean ± 95% confidence 401 
intervals with individual measured responses (B). Real experimental data for nine participants extracted from 402 
Gonzalez et al. (2013). 403 
 404 
Figure 2. Illustrations of the range of area under the curve definitions used throughout the literature. See text 405 
for descriptions and examples for each. 406 
 407 
Figure 3. Hypothetical illustration of an individual measured response to a stimulus across time. The 408 
alternative measured responses on each panel demonstrate when area under the curve, peak and time-to-peak 409 
summary statistics all provide different inferences, requiring cautious and contextual interpretation 410 
 411 
Figure 4. Simple representation of linear interpolation to impute missing data (A), and a hypothetical time 412 
series response demonstrating a key limitation of linear interpolation (B). 413 
